| Summer Lynn Day, MD | |
|
623 S Main St Ste 1, Moscow, ID 83843-2983 | |
| (208) 882-2011 | |
| (208) 883-1853 |
| Full Name | Summer Lynn Day |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 623 S Main St Ste 1, Moscow, Idaho |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457627937 | NPI | - | NPPES |
| 1457627937 | Medicaid | WA | |
| P01733878 | Other | WA | RR MEDICARE WVH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD60572758 (Washington) | Secondary |
| 208000000X | Pediatrics | M-13745 (Idaho) | Primary |
| Entity Name | Gritman Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619988144 PECOS PAC ID: 8729070164 Enrollment ID: O20040402001021 |
News Archive
Evotec AG today announced that it has signed within the "NEU²-Consortium" framework and partially funded by the Federal Ministry of Education and Research (Bundesministerium fuer Bildung und Forschung - BMBF), an agreement with Merck KGaA, Darmstadt, Germany, to develop pre-clinical candidates for an undisclosed neurological disease. Evotec will provide drug discovery expertise covering in vitro biology, medicinal chemistry and in vitro and in vivo pharmacology.
Researchers say that assessing serum albumin levels within 24 hours of admission could be a good prognostic marker of community-acquired pneumonia.
The bivalent oral polio vaccine (bOPV) was found to induce a significantly higher immune response than the existing trivalent oral polio vaccine (tOPV), according to a study published on Tuesday in the journal Lancet, Reuters reports.
Does living in a low-income, densely populated neighborhood such as San Francisco's Tenderloin district predispose you to a higher cancer risk than if you live in an upscale and suburban neighborhood such as San Diego's Rancho Santa Fe? Or vice versa? Scientists at the Cancer Prevention Institute of California now have the data that hold the answers.
Roche and GlaxoSmithKline announced today the submission of a Marketing Authorisation Application to the European authorities for a novel, once-monthly oral formulation of their new bisphosphonate, Bonviva (ibandronate), for the treatment of postmenopausal osteoporosis.
› Verified 6 days ago
| Entity Name | Gritman Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538634522 PECOS PAC ID: 0941545784 Enrollment ID: O20181221002296 |
News Archive
Evotec AG today announced that it has signed within the "NEU²-Consortium" framework and partially funded by the Federal Ministry of Education and Research (Bundesministerium fuer Bildung und Forschung - BMBF), an agreement with Merck KGaA, Darmstadt, Germany, to develop pre-clinical candidates for an undisclosed neurological disease. Evotec will provide drug discovery expertise covering in vitro biology, medicinal chemistry and in vitro and in vivo pharmacology.
Researchers say that assessing serum albumin levels within 24 hours of admission could be a good prognostic marker of community-acquired pneumonia.
The bivalent oral polio vaccine (bOPV) was found to induce a significantly higher immune response than the existing trivalent oral polio vaccine (tOPV), according to a study published on Tuesday in the journal Lancet, Reuters reports.
Does living in a low-income, densely populated neighborhood such as San Francisco's Tenderloin district predispose you to a higher cancer risk than if you live in an upscale and suburban neighborhood such as San Diego's Rancho Santa Fe? Or vice versa? Scientists at the Cancer Prevention Institute of California now have the data that hold the answers.
Roche and GlaxoSmithKline announced today the submission of a Marketing Authorisation Application to the European authorities for a novel, once-monthly oral formulation of their new bisphosphonate, Bonviva (ibandronate), for the treatment of postmenopausal osteoporosis.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Summer Lynn Day, MD 623 S Main St Ste 1, Moscow, ID 83843-2983 Ph: (208) 882-2011 | Summer Lynn Day, MD 623 S Main St Ste 1, Moscow, ID 83843-2983 Ph: (208) 882-2011 |
News Archive
Evotec AG today announced that it has signed within the "NEU²-Consortium" framework and partially funded by the Federal Ministry of Education and Research (Bundesministerium fuer Bildung und Forschung - BMBF), an agreement with Merck KGaA, Darmstadt, Germany, to develop pre-clinical candidates for an undisclosed neurological disease. Evotec will provide drug discovery expertise covering in vitro biology, medicinal chemistry and in vitro and in vivo pharmacology.
Researchers say that assessing serum albumin levels within 24 hours of admission could be a good prognostic marker of community-acquired pneumonia.
The bivalent oral polio vaccine (bOPV) was found to induce a significantly higher immune response than the existing trivalent oral polio vaccine (tOPV), according to a study published on Tuesday in the journal Lancet, Reuters reports.
Does living in a low-income, densely populated neighborhood such as San Francisco's Tenderloin district predispose you to a higher cancer risk than if you live in an upscale and suburban neighborhood such as San Diego's Rancho Santa Fe? Or vice versa? Scientists at the Cancer Prevention Institute of California now have the data that hold the answers.
Roche and GlaxoSmithKline announced today the submission of a Marketing Authorisation Application to the European authorities for a novel, once-monthly oral formulation of their new bisphosphonate, Bonviva (ibandronate), for the treatment of postmenopausal osteoporosis.
› Verified 6 days ago
Guillermo Modad, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 700 S Main St, Moscow, ID 83843 Phone: 208-882-4511 Fax: 208-883-6580 | |
Dr. Jessica Katharine Strong, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1054 Aponi Pl, Moscow, ID 83843 Phone: 250-961-8442 |